|
市場調査レポート
商品コード
1115297
画像誘導治療システムの世界市場規模、シェア、産業動向分析レポート:アプリケーション別、エンドユーザー別、製品別、地域別展望・予測、2022年~2028年Global Image-guided Therapy Systems Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Product, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
画像誘導治療システムの世界市場規模、シェア、産業動向分析レポート:アプリケーション別、エンドユーザー別、製品別、地域別展望・予測、2022年~2028年 |
出版日: 2022年07月29日
発行: KBV Research
ページ情報: 英文 285 Pages
納期: 即納可能
|
画像誘導治療システムの世界市場規模は、予測期間中にCAGR5.4%の市場成長率で上昇し、2028年には55億米ドルに達すると予測されています。
画像誘導を利用した具体的な治療法が増えているとはいえ、これらの治療法は、画像を使って精度を高める旧来の手法と、画像と専用器具を使って切開せずに内臓や組織の状態を治療する最近の手法の2つに大別されます。画像誘導治療に最もよく使用される断面デジタル画像装置は、コンピュータ断層撮影(CT)と磁気共鳴画像(MRI)の2つです。さらに、手術用ナビゲーション技術、トラッキングツール、統合ソフトウェアが、これらの処置をサポートするために使用されています。
IGT(Image Guided Therapy)は、がん治療のための医療用具を作成します。近年、医療界では、局所的な腫瘍の切除に基づく新しいがん治療法が注目されています。局所がんを治療する方法として非常に有望視されているのが熱焼灼療法で、腫瘍を切除するのではなく、腫瘍組織内の温度を致命的な閾値まで上昇させることでその場で消滅させるという理論で行われます。熱焼灼療法は、患者さんの耐容性が非常に高く、入院期間も短くなります。IGTは、FUSまたはHIFUとして知られる集束超音波をベースとした、非侵襲的で患者に優しい画像誘導型焼灼装置を作成しています。
COVID-19の影響度分析
継続的な研究は、基本的なCOVID-19の懸念と将来の有望な可能性を組み込むことを保証するために、研究アプローチを拡張しています。COVID-19の市場への影響を考慮した新しいレポートでは、洞察、分析、予測、予想を行っています。予測期間中、COVID-19は前例のない公衆衛生上の緊急事態であるため、長期的に業界の成長に影響を与える可能性が高いと考えられます。調査アプローチの拡大に加え、継続的な調査により、COVID-19の基本的な懸念事項と将来の潜在的な方向性が含まれていることを保証しています。COVID-19の市場への影響を考慮したこの最新研究では、洞察、分析、予測、予想が含まれています。
市場の成長要因
世界のがん罹患率の上昇
がんは、様々な人種、性的指向、社会経済的地位の人々に影響を及ぼします。がんの予防と治療には進歩が見られますが、がんの罹患率は増加傾向にあるようです。がんは、身体のあらゆる部分に影響を及ぼす可能性のあるあらゆる病気を指す一般的な用語です。悪性腫瘍や新生物は、がんを表す別の言葉として使われています。がんは、異常な細胞が急速に発生し、正常な境界を越えて広がり、他の身体部位に侵入し、最終的には他の臓器に侵入するという一面を持っています。このような作用を「転移」と呼びます。転移は、がん患者さんの主な死因とされています。
画像誘導治療装置の技術進歩
がんの罹患率が年々上昇する中、治療法に対する要求も高まっています。画像誘導システムは、複雑な疾患の診断と治療の両方に広く用いられています。このような背景から、画像誘導治療システムの市場は拡大傾向にあります。がん治療では、がん専門医や放射線科医が患部を見ながら治療を行う必要があります。そこで活躍するのが画像誘導治療システムです。早期発見や治療を希望する患者の増加により、画像誘導治療システムの使用は今後数年間で増加すると予想されます。さらに、画像誘導治療システムの需要を押し上げる要因として、技術の進歩が挙げられます。
市場の抑制要因
低所得国での画像誘導治療の普及率の低さ
画像誘導下手術は、低侵襲で直接視認できない手術であり、カテーテル、マイクロインスツルメント、生検針、内視鏡、レーザーなどのツールが使用されます。MRユニット、ナビゲーションシステム、MR対応機器の設置費用は、通常、百万円から数十万円程度です。また、一般的な手術室と同程度の追加的な年間運営費も、数百万米ドル程度になるであろう。また、年間1,000件の治療を行うとしても、1件の治療ごとに少なくとも数千米ドルの追加費用が発生します。
製品の展望
画像誘導治療システム市場は、製品別にコンピュータ断層撮影(CT)スキャナー、超音波診断装置、磁気共鳴画像装置(MRI)、内視鏡、X線透視装置、陽電子放出断層撮影(PET)、単一光子放出コンピュータ断層撮影(SPECT)に分類されます。内視鏡セグメントは、2021年の画像誘導治療システム市場で最も高い収益シェアを獲得しました。これは、ロボット支援内視鏡手術の利用が増加していることと、機器のコストに起因しています。また、さまざまな処置のための内視鏡ガイド下手術の普及も、その成長を後押ししています。
アプリケーションの展望
画像誘導治療システム市場は、アプリケーション別に心臓外科、脳神経外科、整形外科、泌尿器科、腫瘍外科、消化器科、その他に区分されます。2021年の画像誘導治療システム市場では、消化器内科のセグメントがかなりの収益シェアを示しています。消化器学は、消化器系の問題に焦点を当てた医学の一分野です。この専門分野は、消化管に影響を与える病気に焦点を当てており、消化管には、口から食道までの消化管に沿った器官が含まれます。
エンドユーザー向け展望
エンドユーザー別では、病院、外来手術センター、専門クリニック、研究・学術機関に分類されます。外来手術センター部門は、2021年の画像誘導治療システム市場において、かなりの収益シェアを記録しました。これは、これらのヘルスケア施設が提供する、待ち時間の短縮や大幅な金銭的節約などの利点があるためです。また、同セグメントは、ASCにおける低侵襲処置や入院期間の短縮に対する高い嗜好によって牽引されています。
地域別の展望
地域別に見ると、画像誘導治療システム市場は北米、欧州、アジア太平洋、LAMEAの4地域で分析されています。北米地域は、2021年の画像誘導治療システム市場において最大の収益シェアを獲得しました。これは、同市場がヘルスケアインフラの改善、技術的ブレークスルー、高度な放射線治療の急速な受け入れなどを含むためです。この地域市場は、慢性疾患の増加や人口の高齢化によって拡大しています。今後数年間は、低侵襲のインターベンションや外科手術の領域で民間企業が打ち出した有利な措置が、市場の拡大を促進すると予想されます。
市場参加者がとる主な戦略は、パートナーシップです。Cardinalマトリックスで提示された分析によると、Medtronic PLCとSiemens Healthineers AG(Siemens AG)が画像誘導治療システム市場の先駆者となっています。Koninklijke Philips N.V.、Olympus Corporation、Stryker Corporationなどの企業は、画像誘導治療システム市場における主要な革新者の一人です。
List of Figures
The Global Image-guided Therapy Systems Market size is expected to reach $5.5 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.
In radiation therapy, frequent imaging is used to guide treatment, position the patient, and compare the imaging to the pre-therapy imaging from the treatment plan. Before or during a treatment fraction, the patient is located in the treatment room in the same position as intended from the reference imaging dataset. Cone beam computed tomography (CBCT) data acquired on the treatment machine and planning-related computed tomography (CT) data comparison is an illustration of IGRT.
In addition, digitally reconstructed radiographs (DRRs) from the planning CT would be matched with planar megavoltage (MV) or kilovolt age (kV) images. The use of any type of medical imaging to plan, carry out, and assess therapeutic interventions and surgical operations is known as image-guided therapy, and it is a key idea in 21st-century medicine. Surgery can be made less invasive and more exact with the aid of image-guided treatment techniques, which can result in shorter hospital stays and fewer repeat procedures.
Even though there are increasingly more specific procedures that use image guidance, these procedures fall into one of two broad categories: older techniques that use imaging to improve their accuracy and more recent techniques that use imaging and specialized instruments to treat conditions of internal organs and tissues without making an incision. The two most often used cross-sectional digital imaging modalities for image-guided therapy are computed tomography (CT) and magnetic resonance imaging (MRI). Additionally, surgical navigation technology, tracking tools, and integration software are used to support these procedures.
IGT (Image Guided Therapy) creates medical tools for the treatment of cancer. The medical world has recently given new cancer therapy methods based on local tumor ablation a lot of attention. A very promising method for treating localized cancer is thermal ablation therapy, which works on the theory that the tumor is not removed, but rather eliminated in place by increasing the temperature within the tumorous tissues to a deadly threshold. Patients tolerate thermal ablation procedures extremely well, and they spend less time in the hospital as a result. IGT creates image-guided ablation devices that are non-invasive, patient-friendly, and based on focused ultrasound in this situation also known as FUS or HIFU.
COVID-19 Impact Analysis
The continuous study expands upon the research approach to ensure the incorporation of fundamental COVID-19 concerns and prospective future possibilities. The new report, which considers the market impact of COVID-19, offers insights, analyses, projections, and forecasts. Over the forecast period, COVID-19 will be likely to influence industry growth in a long-term manner due to its unprecedented public health emergency. In addition to expanding the research approach, continuous study ensures that basic COVID-19 concerns and potential future directions are included. In this updated study, which accounts for COVID-19's market impact, insights, analyses, projections, and forecasts are included.
Market Growth Factors
Increasing Cancer Incidence Rates Worldwide
Cancer affects people of various racial backgrounds, sexual orientations, and socioeconomic standings. Although there have been advancements in both cancer prevention and treatment, the incidence of cancer diagnosis appears to be rising. Cancer is a general term used to describe any illness that can affect any part of the body. Malignant tumors and neoplasms are alternative terms used to describe cancer. One aspect of cancer is the rapid emergence of abnormal cells that spread past their normal boundaries, invade other bodily parts, and eventually invade other organs. The term "metastasis" refers to this action. Widespread metastases are the primary cause of cancer patient death.
Technology Advancement Of The Image-Guided Therapy Systems
The demands therapeutic methods are rising as cancer incidence rises quickly year after year. Image-guided systems are widely employed in both the diagnosis and treatment of complex disorders. These elements set the stage for expansion in the market for image-guided treatment systems. Oncologists and radiologists must view the affected area while treating cancer. Systems for image-guided therapy are useful in this situation. The use of image-guided therapy systems is anticipated to increase in the upcoming years due to early detection and an increase in the number of patients seeking treatment. A further factor driving demand for image-guided therapeutic systems is technological advancement.
Market Restraining Factors
The Poor Uptake Of Image-Guided Therapy In Low-Income Nations
The tools used in image-guided surgical procedures, which are typically minimally invasive procedures with limited or absent direct visibility, include catheters, micro-instruments, biopsy needles, endoscopes, and lasers. Installation costs for the MR unit, navigation system, and MR-compatible devices typically range from million to dollars. The additional annual operating expenses, which are comparable to those of a typical OR, would also be about millions of USD. Each treatment would cost at least an additional thousands of USD per year, even if the MR machine provided 1,000 treatments annually.
Product Outlook
On the basis of product, the Image-guided Therapy Systems Market is divided into Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscopes, X-ray Fluoroscopy, Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography (SPECT). The endoscopes segment acquired the highest revenue share in the Image-guided Therapy Systems Market in 2021. It is due to the rising use of robot-assisted endoscopic operations and the cost of the equipment. Its growth has also been aided by the widespread use of endoscope-guided surgery for various procedures.
Application Outlook
Based on the Application, the Image-guided Therapy Systems Market is segmented into Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, and Others. The Gastroenterology segment witnessed a substantial revenue share in the Image-guided Therapy Systems Market in 2021. Gastroenterology is the branch of medicine that focuses on digestive system issues. This specialty focuses on illnesses that affect the gastrointestinal tract, which includes the organs from the mouth into the esophagus along the alimentary canal.
End-Use Outlook
By End-use, the Image-guided Therapy Systems Market is classified into Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Research & Academic Institutions. The Ambulatory Surgical Centers segment recorded a substantial revenue share in the Image-guided Therapy Systems Market in 2021. It is because of the benefits that these healthcare venues provide, including shorter wait times and significant financial savings. The segment is also being driven by a high preference for minimally invasive procedures and shorter hospital stays in ASCs.
Regional Outlook
Region wise, the Image-guided Therapy Systems Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region acquired the largest revenue share in the Image-guided Therapy Systems Market in 2021. It is because the market includes improved healthcare infrastructure, technological breakthroughs, and rapid acceptance of sophisticated radiation therapy. The regional market is expanding as a result of the rising number of chronic diseases and the aging population. In the upcoming years, favorable measures launched by private businesses in the realm of minimally invasive interventional and surgical procedures are anticipated to promote market expansion.
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC and Siemens Healthineers AG (Siemens AG) are the forerunners in the Image-guided Therapy Systems Market. Companies such as Koninklijke Philips N.V., Olympus Corporation, Stryker Corporation are some of the key innovators in Image-guided Therapy Systems Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Analogic Corporation, General Electric (GE) Co. (GE Healthcare), Brainlab AG, Olympus Corporation, and Stryker Corporation.
Recent Strategies Deployed in Image-guided Therapy Systems Market
Partnerships, Collaborations and Agreements:
Jul-2022: Medtronic came into a partnership with MathWorks, an Israel-based cardiovascular disease-focused medical technology firm. Together the companies aimed to deliver new, creative solutions and technologies from diagnosis to therapy.
Apr-2022: Medtronic joined hands with GE Healthcare, a leading global medical technology. Together, the companies focused on the special requirements and need for maintenance at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs). Additionally, consumers can find financial solutions, extensive product offerings, and outstanding service.
Aug-2021: Siemens Healthineers came into a partnership with TeamViewer, a foremost global technology enterprise. Together the companies aimed to allow New Remote Scanning Service WeScan for Diagnostic Imaging. Additionally, WeScan is a new service utilizing TeamViewer's connectivity technology, that allows healthcare suppliers to conduct magnetic resonance imaging (MRI) examinations if they don't have a trained radiology team.
Aug-2021: Royal Philips signed an agreement with NICO.LAB, a MedTech stroke care company. Together with the newly developed stroke abilities of Philips Image Guided Therapy System, Azurion the new partnership particularly promotes Philips' dedication to enhance results for people who suffer a stroke. Additionally, Philips is connecting technologies, information, and people within the stroke care course, allowing care teams to work fast and act critical as a key factor in delivering the finest patient therapy.
Jun-2021: GE Healthcare formed a partnership with the American College of Cardiology, a nonprofit medical association. Together, the companies aimed to produce a roadmap for artificial intelligence (AI) for cardiac supervision and create new techniques for enhanced health effects. Additionally, the partnership would produce new AI for cardiac care and digital technology roadmaps to dive the risks associated to atrial fibrillation management and other connected clinical trails.
Feb-2021: Stryker formed a partnership with Brainomix, an Oxford-based company. Together, the companies aimed to portray a transformative resolution for stroke networks across EMEA, allowing more comprehensive usage of stroke imaging AI devices to assist more patients to achieve permit to life-saving cures.
Feb-2021: Olympus came into a partnership with Imbio, a provider of full quantitative analysis and 3D visualization. Together the companies aimed to assess patient suitability for therapy with the Spiration Valve System, an FDA-designated breakthrough instrument to treat extreme emphysema, a condition of chronic obstructive pulmonary disease.
Product Launches and Product Expansions:
Jun-2022: GE Healthcare launched the Allia platform for minimally invasive, image-guided surgery. The new platform is developed through a multi-year alliance with surgeons and interventionists with the supreme aim of improving the consumer experience, enhancing workflow efficiency, and growing adoption of developed image guidance in daily routine.
Mar-2022: Siemens Healthineers unveiled MAGNETOM Free.Star along with NAEOTOM Alpha, special solutions in MRI and CT portfolio. These solutions are driven by artificial intelligence are useful for nations such as India where is a requirement to fill the gap between the need for developed devices and the lack of trained experts supervising the processes.
Feb-2022: Siemens Healthineers introduced Artis icono biplane, an angiography system. The new Artis icono biplane delivers unique qualities for treating and diagnosing coronary heart disease, cardiac arrhythmia, and structural heart disease that streamline clinical workflows and delivers superior image quality at a lower radiation dose
Feb-2021: Royal Philips unveiled ClarifEye Augmented Reality Surgical Navigation, a new image-guided therapy solution. The new device is developed to offer minimally-invasive spine techniques in the hybrid operating room including Philips' Hybrid offering. Moreover, Philips' new solution integrates 2D and 3D visualizations at low X-ray amounts with 3D augmented reality (AR) to provide live intra-operative visual responses to help exactly place pedicle screws during spinal fusion treatment.
Acquisitions and Mergers:
May-2022: Brainlab completed the acquisition of medPhoton, a developer, that makes robotic imaging for image-guided radiation therapy and surgery. With this acquisition, the company aimed to construct on the earlier conquest of Loop-X and significantly influence the fortune of intraoperative imaging. Moreover, to the extent the market situation of Loop-X as a 3D imaging device for surgery so that doctors can achieve key to cutting-edge tools for patient therapy.
Jan-2022: Medtronic completed the acquisition of Affera, a Boston area-based, personally held medical technology firm. This acquisition would expand Medtronic's offering of developed cardiac ablation products and supplements to fulfill physician requirements within an increasing patient population.
Dec-2021: Royal Philips completed the acquisition of Vesper Medical Inc., a US-based medical technology firm. With this acquisition, Vesper Medical would further extend Philips' offering of therapeutic and diagnostic devices with a developed venous stent suite for the therapy of deep venous disorder.
Dec-2021: GE completed the acquisition of BK Medical, a head in advanced surgical visualization. Through this acquisition, GE Healthcare counts the fast-developing and fairly new field of real-time surgical visualization within GE's pre- and post-operative Ultrasound abilities, forming an end-to-end portfolio through the complete continuum of care from diagnosis via treatment and beyond.
May-2021: GE Healthcare took over Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers. Under this acquisition, the company aimed to convey Zionexa's pipeline biomarkers, along with the newly FDA-approved PET imaging agent, Cerianna, which is utilized as an adjunct to biopsy for the identification of estrogen receptor (ER) favorable lesions to assist inform therapy selection for patients with recurrent or metastatic breast cancer.
Jan-2021: Olympus Corporation completed the acquisition of Quest Photonic Devices B.V., a multispectral imaging leader. With this acquisition, Olympus would reinforce its status as a world leader in medical imaging solutions, and provides creative abilities to surgeons, to create the invisible visible.
Aug-2020: Royal Philips took over Intact Vascular, a medical device company. Through this acquisition, Vascular would improve Philips' image-guided treatment offering, integrating Philips' interventional imaging platform and diagnostic and therapeutic devices within Intact Vascular's unique, technical implantable instrument to optimize the therapy of patients with peripheral arterial disease (PAD).
Approvals and Trials:
Jan-2021: Siemens Healthineers received Food and Drug Administration approval for MAGNETOM Free.Max, a new High-V magnetic resonance scanner. The device combines a 0.55 Tesla field power with profound learning technologies and developed image processing. Additionally, the scanner widens the field of MR clinical applications and delivers consumers the ingrained clinical advantages of a mid-field MR scanner.
Market Segments covered in the Report:
By Application
By End-Use
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research